Biogen Inc
SGO:BIIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
SGO:BIIB
|
US |
|
BT Group PLC
OTC:BTGOF
|
UK |
|
Journey Medical Corp
NASDAQ:DERM
|
US |
|
Bubs Australia Ltd
OTC:BUBSF
|
AU |
|
ARC Document Solutions Inc
NYSE:ARC
|
US |
|
C
|
Chesapeake Energy Corp
XBER:CS1
|
US |
|
NN Group NV
AEX:NN
|
NL |
|
S
|
Swire Pacific Ltd
F:SWI1
|
HK |
|
T
|
Thunder Bridge Capital Partners IV Inc
NASDAQ:THCP
|
US |
|
Chicago Atlantic Real Estate Finance Inc
NASDAQ:REFI
|
US |
|
D
|
Deliveroo PLC
OTC:DROOF
|
UK |
|
Watsco Inc
F:WC30
|
US |
|
Widodo Makmur Unggas Tbk PT
IDX:WMUU
|
ID |
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
OTC:RCDTF
|
IT |
|
Calibre Mining Corp
TSX:CXB
|
CA |
|
F
|
Fluor Corp
SWB:FLU
|
US |
|
I
|
Insurance Australia Group Ltd
OTC:IAUGF
|
AU |
|
S
|
Sirius XM Holdings Inc
DUS:RDO
|
US |
|
CuriosityStream Inc
NASDAQ:CURI
|
US |
|
T
|
Telus Corp
F:BCZ
|
CA |
|
G
|
Galp Energia SGPS SA
SWB:GZ5
|
PT |
|
G
|
Gazprom PAO
F:GAZ
|
RU |
|
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
|
CN |
|
Microbot Medical Inc
NASDAQ:MBOT
|
US |
Wall St Price Targets
BIIB Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for BIIB is 276.13 USD with a low forecast of 188.04 USD and a high forecast of 358.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BIIB's stock price target?
Price Target
276.13
USD
According to Wall Street analysts, the average 1-year price target for BIIB is 276.13 USD with a low forecast of 188.04 USD and a high forecast of 358.4 USD.
What is the Revenue forecast for Biogen Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 0%.
What is the Operating Income forecast for Biogen Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 1%.
What is the Net Income forecast for Biogen Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 9%.
